Filing Details
- Accession Number:
- 0001127602-18-010592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 16:56:55
- Reporting Period:
- 2018-03-06
- Accepted Time:
- 2018-03-07 16:56:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-06 | 24,008 | $88.05 | 325,684 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-06 | 24,008 | $110.00 | 301,676 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-03-06 | 24,008 | $0.00 | 24,008 | $88.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
72,025 | 2018-02-24 | 2022-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 10,208 | Indirect | 2016 GRAT |
Common Stock | 29,954 | Indirect | 2017 GRAT |
Common Stock | 340 | Indirect | By Trust |
Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.